Literature DB >> 17598369

Centropontine myelinolysis after correction of hyponatremia: role of associated hypokalemia.

A E Heng1, P Vacher, B Aublet-Cuvelier, J M Garcier, V Sapin, P Deteix, B Souweine.   

Abstract

BACKGROUND: Patients with severe hyponatremia have a high risk for centropontine myelinolysis (CPM) during treatment, but the incidence rate and risk factors have not been well-assessed.
METHODS: This study was conducted in a medical intensive care unit (ICU) of a university teaching hospital. All patients with a serum sodium concentration < 120 mmol/l and a serum osmolality level < 250 mosmol/kg upon ICU admission were enrolled in this prospective study and were included if they underwent a baseline brain computerized tomography scan (CT scan) and a follow-up brain magnetic resonance imaging 1 month after admission. The diagnosis of CPM was based on cerebral magnetic resonance imaging findings, i.e. T1-weighted images with T2-weighted images showing hyperintense signal in the corresponding areas which were not apparent on the initial cerebral CT scan. RESULTS. Of the 22 patients included, 12 were considered as having acute hyponatremia and 8 were chronic alcoholics. In 12 patients, the increase in serum sodium level was < 12 mmol/I in any 24-hour period. CPM was diagnosed in 7/22 patients (31.8%) and was asymptomatic in 4 of them. CPM was present in 4 patients with acute hyponatremia and in 4 chronic alcoholics. It was associated with a lower baseline potassium level (p = 0.05) and NaCl administration during the first 24 hours (p = 0.005). However, non-acute hyponatremia, chronic alcoholism and rapid correction of serum sodium did not appear as risk factors.
CONCLUSION: The incidence rate of CPM following severe hyponatremia is high and can develop even when there is a slow correction of serum sodium level. Hypokalemia is a predisposing factor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17598369     DOI: 10.5414/cnp67345

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  9 in total

1.  Central pontine myelinolysis: electrolytes and beyond.

Authors:  J V Mascarenhas; E B Jude
Journal:  BMJ Case Rep       Date:  2014-03-28

2.  Central pontine myelinolysis: historical and mechanistic considerations.

Authors:  Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2010-02-25       Impact factor: 3.584

3.  Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia.

Authors:  Jason C George; Waleed Zafar; Ion Dan Bucaloiu; Alex R Chang
Journal:  Clin J Am Soc Nephrol       Date:  2018-06-05       Impact factor: 8.237

4.  Desmopression is an effective adjunct treatment for reversing excessive hyponatremia overcorrection.

Authors:  Kamel A Gharaibeh; Matthew J Craig; Christian A Koch; Anna A Lerant; Tibor Fülöp; Eva Csongrádi
Journal:  World J Clin Cases       Date:  2013-08-16       Impact factor: 1.337

5.  Extra pontine osmotic demyelination syndrome.

Authors:  Pervaiz M Zunga; Omar Farooq; Mohd I Dar; Ishrat H Dar; Samia Rashid; Abdul Q Rather; Javid A Basu; Mohammed Ashraf; Jahangeer A Bhat
Journal:  Ann Neurosci       Date:  2015-01

6.  Hyponatremia in the intensive care unit: How to avoid a Zugzwang situation?

Authors:  Cédric Rafat; Martin Flamant; Stéphane Gaudry; Emmanuelle Vidal-Petiot; Jean-Damien Ricard; Didier Dreyfuss
Journal:  Ann Intensive Care       Date:  2015-11-09       Impact factor: 6.925

7.  Osmotic demyelination syndrome following slow correction of hyponatremia: Possible role of hypokalemia.

Authors:  Parvaiz A Koul; Umar Hafiz Khan; Rafi A Jan; Sanaullah Shah; Abdul Baseer Qadri; Burhan Wani; Mohammed Ashraf; Feroze Ahmad; Sajjad R Bazaz
Journal:  Indian J Crit Care Med       Date:  2013-07

8.  Clinical Evolution of Central Pontine Myelinolysis in a Patient with Alcohol Withdrawal: A Blurred Clinical Horizon.

Authors:  Abdul S Mohammed; Prajwal Boddu; Dina F Yazdani
Journal:  Case Rep Med       Date:  2016-08-16

9.  A Survey of Hospital Pharmacy Guidelines for the Administration of 3% Sodium Chloride in Children.

Authors:  Siddharth A Shah; Juan C Ayus; Michael L Moritz
Journal:  Children (Basel)       Date:  2022-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.